,,ii  #aagth ,,congress  #b;d ,session  
,s4 #ddfg  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,june #bc1     
#bjbb,ms4 ,smith introduced the         
following bill2 which was read twice and
 referred to the ,committee on ,health1 
,education1 ,labor1 and ,pensions  ,a   
,,bill  ,to preserve access to abortion 
medications4  #a4 ,short title ,this    
,act may be cited as the ,protecting    
,access to ,medication ,abortion ,act4  
#b4 ,modification of ,,rems  7a7 ,in    
general ,the ,secretary of ,health and  
,human ,services 7referred to in this   
section as the ,secretary7 shall require
 the responsible person involved to     
submit a proposal under subsection      
7g77#d77;,a7 of section #eje-a of the   
,federal ,food1 ,drug1 and ,cosmetic    
,act 7#ba ,u4,s4,c4 #cee-a7 to modify   
the risk evaluation and mitigation      
strategy under such section that applies
 to mifepristone so that-- 7#a7 the     
in-person dispensing requirement is     
removed from such risk evaluation and   

mitigation strategy2  7#b7 patients may 
access prescriptions for such drug via  
telehealth2 and  7#c7 all pharmacies    
that are certified to dispense such drug
 are permitted to1 at minimum1 dispense 
and mail such drug to patients4  7b7    
,modifications ,nothing in subsection   
7a7 shall be construed to prevent the   
,secretary from approving a modification
 to the risk evaluation and mitigation  
strategy for mifepristone based on sound
 scientific evidence and in accordance  
with section #eje-a7;h7 of the ,federal 
,food1 ,drug1 and ,cosmetic ,act 7#ba   
,u4,s4,c4 #cee-a7;h774 ,any             
modifications to such risk evaluation   
and mitigation strategy made after the  
proposal to modify required pursuant to 
subsection 7a7 shall be in accordance   
with the requirements under paragraphs  
7#a71 7#b71 and 7#c7 of such subsection1
 unless the ,secretary1 based on sound  
scientific evidence and in accordance   
with section #eje-a of such ,act 7#ba   
,u4,s4,c4 #cee-a71 determines that a    

risk evaluation and mitigation strategy 
for mifepristone is no longer necessary4
  7c7 ,clarification ,nothing in        
subsection 7a7 shall be construed to    
limit the authority of the ,secretary to
 impose the requirements described in   
paragraphs 7#a71 7#b71 and 7#c7 of such 
subsection to a risk evaluation and     
mitigation strategy under section #eje-a
 of the ,federal ,food1 ,drug1 and      
,cosmetic ,act 7#ba ,u4,s4,c4 #cee-a7   
for any drug other than mifepristone4   
7d7 ,definition ,in this section1 the   
term mifepristone means mifepristone    
that is-- 7#a7 approved under subsection
 7c7 or 7j7 of section #eje of the      
,federal ,food1 ,drug1 and ,cosmetic    
,act 7#ba ,u4,s4,c4 #cee72  7#b7        
indicated for medical abortion2 and     
7#c7 subject to a risk evaluation and   
mitigation strategy under section #eje-a
 of the ,federal ,food1 ,drug1 and      
,cosmetic ,act 7#ba ,u4,s4,c4 #cee-a74